Singh et al. have also found that treatment of non-small cell lung cancer cells with Honokiol suppresses the levels of class I HDAC proteins and HDAC activity while enhances the HAT activity in vitro and in vivo (Singh et al. 2013). This evidence concerns the gene TMPRSS11D and non-small cell lung carcinoma.